Host Defence Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK Imperial College London, London, UK.
Imperial College London, London, UK Electron Microscopy Dept, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Eur Respir J. 2016 Aug;48(2):441-50. doi: 10.1183/13993003.00209-2016. Epub 2016 Jun 10.
Primary ciliary dyskinesia (PCD) in adults has not been well described. In this retrospective observational study we aimed to characterise a large adult population and identify features associated with disease progression.We retrospectively analysed 151 adult patients at a single tertiary centre at baseline and longitudinally for a median of 7 years.We found significant variation in age at diagnosis (median 23.5 years; range <1-72 years). Older age at diagnosis was associated with impaired baseline forced expiratory volume in 1 s (FEV1) (r= -0.30, p=0.01) and increased Pseudomonas aeruginosa colonisation (difference in medians 17 years (95% CI 4.5-20 years); p=0.002). Lung function decline was estimated at FEV1 decline of 0.49% predicted per year. Lung function decline was associated with ciliary ultrastructure, with microtubular defect patients having the greatest decline (p=0.04). High-resolution computed tomography (HRCT) scores of severity of bronchial wall dilatation (p<0.001) and extent of bronchiectasis (p=0.03) additionally showed evidence of modifying FEV1 decline with age.Our study reveals that a large proportion of adult PCD patients are diagnosed late, with impaired FEV1 and increased P. aeruginosa colonisation. Increased disease burden on HRCT and ciliary ultrastructure may predict progressive lung function decline. This study characterises a large adult PCD population, identifies features associated with disease progression and highlights the need for prospective trials to determine whether early diagnosis of high-risk subgroups alongside optimal management can modify disease progression.
原发性纤毛运动障碍(PCD)在成人中尚未得到很好的描述。在这项回顾性观察研究中,我们旨在描述一个大型的成年人群,并确定与疾病进展相关的特征。
我们在单一的三级中心对 151 名成年患者进行了回顾性分析,基线时中位随访 7 年。
我们发现诊断时的年龄存在显著差异(中位数 23.5 岁;范围 <1-72 岁)。诊断时年龄较大与基线时用力呼气量 1 秒(FEV1)受损(r=-0.30,p=0.01)和铜绿假单胞菌定植增加相关(中位数差异 17 岁(95%CI 4.5-20 岁);p=0.002)。肺功能下降估计为每年 FEV1 下降 0.49%。肺功能下降与纤毛超微结构有关,微管缺陷患者下降最大(p=0.04)。支气管壁扩张严重程度的高分辨率计算机断层扫描(HRCT)评分(p<0.001)和支气管扩张程度(p=0.03)也显示出与年龄相关的 FEV1 下降的修饰作用。
我们的研究表明,很大一部分成年 PCD 患者诊断较晚,存在 FEV1 受损和铜绿假单胞菌定植增加。HRCT 和纤毛超微结构上的疾病负担增加可能预示着肺功能的进行性下降。本研究描述了一个大型的成年 PCD 人群,确定了与疾病进展相关的特征,并强调需要前瞻性试验来确定是否可以通过早期诊断高危亚组和最佳管理来改变疾病进展。